Operation Warp Speed: implications for global vaccine securityOperation Warp Speed: 글로벌 백신 보안에 미치는 영향Review Published on 2021-07-012022-09-11 Journal: The Lancet. Global health [Category] 신약개발, 임상, [키워드] AstraZeneca clinical testing COVID-19 COVID-19 vaccines develop Efficacy effort Emergency use equity Expanded access funding global effort group Health implication Informed consent Interim analyses interim analysis Johnson & Johnson Johnson & Johnson Justice mechanism Microbiology Moderna nine Novavax operation Pfizer Phase 3 populations provided question Sinopharm Sinovac speed transition Vaccine [DOI] 10.1016/S2214-109X(21)00140-6 PMC 바로가기 [Article Type] Review
COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responsesCOVID-19 최적 백신 접종 정책: 효능, 자연 및 백신 유도 면역 반응에 대한 모델링 연구Article Published on 2021-07-012022-09-11 Journal: Mathematical biosciences [Category] 변종, [키워드] accumulate confirmed case country Coverage COVID-19 DALYs death develop dominant dose Efficacy evaluate fraction Health Hospitalization hypothetical identify implication induce Intervention life lockdown Logistic Mask Moderna natural natural immunity new SARS-CoV-2 Optimal control pandemic permanent immunity Pfizer Protective quantified recommendations Reinfection required response responses risk the vaccine vaccination Vaccination policy Vaccine vaccine efficacy Vaccine profile Vaccine-induced immunity variant WHO-SAGE. [DOI] 10.1016/j.mbs.2021.108614 PMC 바로가기 [Article Type] Article
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA VaccinesCommunication Published on 2021-06-302022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Anti-spike anti-spike protein IgG Antibody Response Arm CD4+ T-cell Cohort COVID-19 COVID-19 mRNA vaccine COVID-19 mRNA vaccines COVID-19 vaccination elicit elicited high risk host immunity IgG IgM immune Immunocompromised immunogenic Immunosuppression information lung transplantation marker median Moderna mRNA naïve naïve subject nucleocapsid Patient patients Pfizer Pfizer-BioNTech positive Protein recipient recipients regimen response SARS-CoV-2 serological response serum sample significantly spike the SARS-CoV-2 Transplant tropism of SARS-CoV-2 two doses uninfected Vaccine vaccine dose Vaccines were assessed [DOI] 10.3390/vaccines9070708 PMC 바로가기 [Article Type] Communication
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or VaccinationArticle Published on 2021-06-252022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] anti-N IgG Anti-RBD IgG anti-S IgG AstraZeneca avidity B.1.1.7 B.1.351 BNT162b2 ChAdOx1 concern contribute convalescent COVID-19 cVNT demonstrated detectable development domain Evidence examined humoral immune response Humoral immunity IgG immune response immunoblot Immunoglobulin increase in Infection Maturity Moderna mRNA-1273 neutralization Pfizer/BioNTech RBD reactivity robust SARS-CoV-2 SARS-COV-2 infection second dose sera Specific starting sVNT tested titer vaccination vaccine dose vaccinee vaccinees variants of concern viral spike virus variants virus-neutralizing antibodies virus-neutralizing antibody VoC was determined were used [DOI] 10.3390/vaccines9070700 PMC 바로가기 [Article Type] Article
[ 18 F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impactMolecular Imaging Published on 2021-06-222022-10-31 Journal: European Radiology [Category] COVID-19, MERS, SARS, [키워드] affected analyzed BNT162b2 clinical clinical impact Clinical management COVID-19 vaccination COVID-19 vaccines evaluated FDG Fluorodeoxyglucose F18 Frequency injection intensity ipsilateral knowledge Lymph node lymph nodes management metastatic Moderna mRNA-1273 objective Patient PET/CT Pfizer-BioNTech Point positron-emission tomography primary cancer receiving recommendation Result risk screened second vaccination significantly more SUV the vaccine unlikely vaccination Vaccine Vaccines was measured with COVID-19 [DOI] 10.1007/s00330-021-08122-2 PMC 바로가기 [Article Type] Molecular Imaging
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women임산부와 수유부에서 코로나19 mRNA 백신의 면역원성Article Published on 2021-06-152022-09-11 Journal: JAMA [Category] MERS, SARS, 변종, 진단, [키워드] antibody Antibody Response Antibody titers assays B.1.1.7 B.1.351 B.1.351 variant B.1.351 variants binding binding and neutralizing antibodies binding domain Blood BNT162b2 breast milk CD4 CD8 T-cell response CD8 T-cell responses Cellular immune response Cord blood COVID-19 COVID-19 vaccine COVID-19 vaccine trials COVID-19 vaccines cross-reactive antibody enrolled enzyme enzyme-linked immunospot evaluate evaluated excluded exploratory Exploratory analysis Fever Follow-up functional Humoral and cellular immune responses IFN-γ immune responses immunogenic immunogenicity ImmunoSpot increased risk lactating lactating women Messenger RNA Moderna morbidity morbidity and mortality mRNA mRNA vaccine mRNA-1273 Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers nonpregnant outcome Pfizer-BioNTech Phase 3 Population pregnant pregnant women preserved prospective cohort study receipt reduced reported response SARS-CoV-2 B.1.1.7 SARS-COV-2 infection SARS-CoV-2 receptor SARS-CoV-2 USA-WA1/2020 SARS-CoV-2 variant SARS-CoV-2 variants Spike-specific T-cell responses T-cell Response T-cell responses the SARS-CoV-2 transported vaccination Vaccine vaccine dose Viral Viral variants were assessed white women [DOI] 10.1001/jama.2021.7563 PMC 바로가기 [Article Type] Article
Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine017 Published on 2021-06-102022-10-28 Journal: Transplantation Direct [Category] COVID-19, [키워드] acute respiratory syndrome Attitude conducted Critical distribution Efficacy female foundation Inc. lack Major Moderna mRNA-1273 vaccine National Organ transplant populations PROTECT receive receiving recipient reported respondent SARS-CoV-2 SARS-CoV-2 vaccine Side effect solid organ transplant Transplant Vaccine white [DOI] 10.1097/TXD.0000000000001171 PMC 바로가기 [Article Type] 017
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 VaccinesCardiology Published on 2021-06-102022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Biomarker CAD Cardiomyopathy cardiovascular Case series case sery changes Chest chest pain clinically suspected Complication Coronary artery disease coronavirus disease COVID-19 COVID-19 disease described diagnosed Dyspnea ECG elevated Elevation healthy inflammatory markers Lake magnetic resonance imaging men Moderna mRNA-based mRNA-based COVID-19 vaccine myocarditis Other Patient Pericarditis Pfizer-BioNTech receiving reduced reported second dose Stress Stress cardiomyopathy substernal Symptoms the vaccine Vaccine ventricular [DOI] 10.7759/cureus.15576 PMC 바로가기 [Article Type] Cardiology
Vaccine Breakthrough Infections with SARS-CoV-2 VariantsSARS-CoV-2 변이체를 사용한 백신 돌발 감염Case Reports Published on 2021-06-102022-09-11 Journal: The New England Journal of Medicine [Category] MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 BNT162b2 Breakthrough infection Cohort coronavirus coronavirus disease Coronavirus disease 2019 D614G diagnose E484K Efficacy effort Evidence evidence of Infection Moderna mRNA mRNA-1273 Mutation observation of BNT162b2 Pfizer-BioNTech polymerase positive potential risk Prevent respiratory SARS-CoV-2 second dose Sequencing severe acute respiratory syndrome Coronavirus subsequent Support Symptom tested vaccination Vaccine vaccine efficacy variant variants Viral virus women [DOI] 10.1056/NEJMoa2105000 PMC 바로가기 [Article Type] Case Reports
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesCOVID-19 백신에 대한 중증 알레르기 반응의 진단, 관리 및 예방에 관한 EAACI 성명Article Published on 2021-06-012022-09-11 Journal: Allergy [Category] MERS, SARS, 진단, 치료기술, [키워드] absence Academy administer agency Algorithm allergen allergic allergic disease allergic reaction Allergic reactions allergy anaphylaxis approach approaches approval approved AstraZeneca BNT162b2 ChAdOx1-S clinical component components COVID COVID-19 vaccine COVID-19 vaccines desensitization Diagnosis disease equipment European facilitate first dose identify include injection International list management medication medications Moderna mRNA mRNA-1273 mRNA-based vaccine mRNA-based vaccines occur Patient Pfizer/BioNTech Precision recommendation regulatory agencies regulatory agency reported Research resolved responsible risk SARS-CoV severe allergic reaction severe allergic reactions state the vaccine Treatment union United Kingdom vaccination Vaccinations Vaccine virus workup [DOI] 10.1111/all.14739 PMC 바로가기 [Article Type] Article